Delivery Order SPE2DR25D7058-SPE2DR26F8DSW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs at a ceiling value of $1,349.88. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award is expected to be completed by December 10, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $1,349.88 and an ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,773.10 to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 6, 2026, for the supply of Epidiolex 100 mg/ml oral solution in 100 ml packs. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,349.90 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml oral solution on December 10, 2025, with completion expected by December 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through open procurement. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Epidiolex is a cannabidiol-based...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,682.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Epidiolex 100 mg/ml solution in a 100 ml pack. This non-set-aside competitive award is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is a cannabidiol-based pharmaceutical used primarily for seizure management, reflecting the federal government's medical supply procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,699.76 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 6, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol product primarily used for treating certain seizure disorders....
- The Defense Logistics Agency awarded a delivery order valued at $2,659.65 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/ml solution in 100 ml packs. The contract, which is not set-aside and employs firm fixed price terms, was awarded on December 12, 2025, with an ultimate completion date of January 6, 2026. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.64 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 60ml packaging. The order was issued on November 18, 2025, with an ultimate completion date of December 10, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order through its corporate office division. The...
- The Defense Logistics Agency awarded a $1,349.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs. This is a firm fixed-price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol-based medication primarily used for the treatment of seizure disorders, particularly in pediatric...
- SPE2DR25D7058Indefinite Delivery Contract
- SPE2DR25D7058-SPE2DR26F8DSWDelivery Order
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,349.90 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 60mL packs. This firm fixed-price delivery order is unclassified and has an ultimate completion date of February 10, 2026. The award was competitively procured without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies, particularly the Department of Defense and Veterans Affairs. This delivery order is issued under a larger Indefinite Delivery Contract vehicle held by Cencora, Inc. with DLA Troop Support Medical (valued at $999,999,999.00 through December 2031), which provides comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. Epidiolex, an FDA-approved cannabidiol formulation, is a specialized pharmaceutical product used in neurological treatment regimens. The relatively modest order value reflects a routine procurement action within the broader strategic partnership between DLA and Cencora for maintaining critical pharmaceutical inventories across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/19/26 |